Story perspectives

Nara Organics Infant Formula Recalled After Botulism Outbreak

6/14/2026

Summary

Nara Organics Recalls Formula

Nara Organics recalled its infant formula in the United States on June 13, 2026 after a botulism outbreak.
Three infants 2-5 in California, Pennsylvania and Washington fell ill in April-May 2026 and were hospitalized and treated with BabyBIG®, the FDA-approved IV therapy.
The FDA and CDC told parents to stop using the product, label cans “DO NOT USE,” and monitor infants, while officials collected cans for testing and expect results in weeks.

Summary

Nara Organics Recall

The FDA urged Nara Organics on June 12, 2026 to recall the formula because of outbreak severity.
Nara Organics agreed on June 13, 2026 to recall all Whole Milk Organic Powdered Infant Formula made in Europe.
The product sold nationwide through Target stores, Target.com and Nara.com from July 2025 to June 2026.
Officials say the recall, covering under 1% of U.S. formula sales, should not cause a shortage.

Summary

US Faces Botulism

The United States experienced its second infant-formula-linked botulism outbreak in under a year.
The November 2025 outbreak was traced to ByHeart Whole Nutrition Infant Formula and sickened 48 infants in 17 states.
Whole-genome sequencing linked both the ByHeart and Nara Organics cases to Clostridium botulinum found in organic whole-milk powder.
Seattle food-safety attorney Bill Marler warned that the recurring contamination of whole-milk powdered formula is especially troubling.

Summary

CDC Alerts

Parents must discard unopened cans or return them, label opened cans “DO NOT USE” for one month, photograph lot and use-by date, and clean bottles, utensils, surfaces that touched formula with water or dishwasher.
CDC urges monitoring infants a month and seeking care if baby shows poor feeding, head-control loss, difficulty swallowing, or reduced facial expression.
In Salem, 300 children lost speech and occupational therapy services after recall disrupted clinic.

1 of 4

Nara Organics Recalls Formula

Nara Organics recalled its infant formula in the United States on June 13, 2026 after a botulism outbreak.
Three infants 2-5 in California, Pennsylvania and Washington fell ill in April-May 2026 and were hospitalized and treated with BabyBIG®, the FDA-approved IV therapy.
The FDA and CDC told parents to stop using the product, label cans “DO NOT USE,” and monitor infants, while officials collected cans for testing and expect results in weeks.

1 / 4